|
PKI 14-22 amide,myristoylated
|
PKI 14-22 AMIDE, MYRISTOYLATED
|
201422-03-9
|
|
GIP (3-42), human
|
GIP (3 - 42), human
|
1802086-25-4
|
|
Tirabrutinib
|
替拉魯替尼
|
1351636-18-4
|
|
Tegatrabetan
|
1227637-23-1
|
1227637-23-1
|
|
Formononetin
|
刺芒柄花素
|
485-72-3
|
|
Insulin(cattle)
|
牛胰島素
|
11070-73-8
|
|
c-Fms-IN-2
|
791587-67-2
|
791587-67-2
|
|
FzM1.8
|
Fzd4 agonist FzM1.8)
|
2204290-85-5
|
|
IWP-O1
|
IWP-O1
|
2074607-48-8
|
|
Trapidil
|
樂可安
|
15421-84-8
|
|
Y-27632
|
Y-27632二鹽酸鹽
|
146986-50-7
|
|
TBCA
|
Casein Kinase II Inhibitor III
|
934358-00-6
|
|
CGP77675
|
CGP 77675; CGP-77675
|
234772-64-6
|
|
JI-101
|
JI-101
|
900573-88-8
|
|
Crizotinib hydrochloride
|
克里唑替尼鹽酸
|
1415560-69-8
|
|
CCT241736
|
CS-2683
|
1402709-93-6
|
|
LF3
|
LF3
|
664969-54-4
|
|
Casein Kinase II Inhibitor IV
|
863598-09-8
|
863598-09-8
|
|
Pexidartinib hydrochloride
|
培西達(dá)替尼鹽酸鹽
|
2040295-03-0
|
|
YAP/TAZ inhibitor-1
|
2-((4,4-dimethylcyclohexyl)sulfonyl)-7-((4-(1-phenylethyl)piperazin-1-yl)sulfonyl)-9H-fluoren-9-one oxime
|
2093565-23-0
|
|
H-89
|
N-[2-[P-溴苯丙烯鹽基氨基]乙基]-5-異喹啉磺酰胺
|
127243-85-0
|
|
SANT-1
|
SANT1
|
304909-07-7
|
|
Bilobetin
|
7-去甲基銀杏雙黃酮
|
521-32-4
|
|
Tyrphostin A9
|
酪氨酸磷酸化抑制劑A9
|
10537-47-0
|
|
BIBF 1202
|
BIBF 1202
|
894783-71-2
|
|
Adavivint
|
SM04690
|
1467093-03-3
|
|
MRT00033659
|
MRT00033659
|
1401731-54-1
|
|
SYN1143
|
N-[3-氟-4-[(7-甲氧基喹啉-4-基)氧基]苯基]-1-(2-羥基-2-甲基丙基)-5-甲基-3-氧代-2-苯基-2,3-二氫-1H-吡唑-4-甲酰胺
|
913376-84-8
|
|
CUR61414
|
CUR 61414
|
334998-36-6
|
|
Neurodazine
|
2-[5-(3-Chlorophenyl)-2-furanyl]-4,5-bis(4-methoxyphenyl)-1H-imidazole
|
937807-66-4
|
|
Y-33075 dihydrochloride
|
Y39983 HYDROCHLORIDE
|
173897-44-4
|
|
WAY-262611
|
MAY-262611
|
1123231-07-1
|
|
AMG 925
|
AMG-925
|
1401033-86-0
|
|
PP58
|
Pyrido[2,3-d]pyrimidin-7(8H)-one,2-[[4-(2-aminoethoxy)phenyl]amino]-6-(2,6-dichlorophenyl)-8-methyl-
|
212391-58-7
|
|
SCR-1481B1
|
麥他替尼胺丁三醇
|
1174161-86-4
|
|
GNF-6231
|
GNF6231
|
1243245-18-2
|
|
SKL2001
|
SKL2001
|
909089-13-0
|
|
ASP5878
|
ASP-5878
|
1453208-66-6
|
|
DDR Inhibitor
|
1644069-80-6
|
1644069-80-6
|
|
DK419
|
DK419
|
2102672-22-8
|
|
ROCK inhibitor-2
|
ROCK inhibitor-2
|
1127308-52-4
|
|
Bevacizumab
|
貝伐珠單抗
|
216974-75-3
|
|
CREBtide
|
多肽CREBtide
|
149155-45-3
|
|
A 419259 trihydrochloride
|
7-[反式-4-(4-甲基-1-哌嗪基)環(huán)己基]-5-(4-苯氧基苯基)-7H-吡咯并[2,3-D]嘧啶-4-胺三鹽酸鹽
|
1435934-25-0
|
|
QL47
|
1469988-75-7
|
1469988-75-7
|
|
Porcn-IN-1
|
Porcupine-IN-1
|
2036044-77-4
|
|
ALLO-2
|
ALLO-2
(Smo inhibitor ALLO-2)
|
1357350-60-7
|
|
Metadoxine
|
美他多辛
|
74536-44-0
|
|
Linifanib
|
利尼伐尼
|
796967-16-3
|
|
Vismodegib
|
維莫德吉
|
879085-55-9
|
|
EOC317
|
ACTB-1003
|
939805-30-8
|
|
TAK-593
|
1005780-62-0
|
1005780-62-0
|
|
ZINC00881524
|
557782-81-7
|
557782-81-7
|
|
DDR1-IN-2
|
DDR1-IN-2
|
1429617-90-2
|
|
MSAB
|
MSAB
|
173436-66-3
|
|
c-Fms-IN-1
|
C-FMS-IN-1
|
885703-64-0
|
|
Tanshinone IIA
|
丹參酮 IIA
|
568-72-9
|
|
Fangchinoline
|
防己諾林堿
|
436-77-1
|
|
Y-33075
|
(R)-4-(1-氨基乙基)-N-1H-吡咯并[2,3-B]吡啶-4-基苯甲酰胺
|
199433-58-4
|
|
BMX-IN-1
|
N-[2-甲基-5-[9-[4-[(甲基磺?；?氨基]苯基]-2-氧代苯并[H]-1,6-萘啶-1(2H)-基]苯基]-2-丙烯酰胺
|
1431525-23-3
|
|
CEP-37440
|
CEP-37440
|
1391712-60-9
|
|
iCRT3
|
CS-2716
|
901751-47-1
|
|
NAMI-A
|
201653-76-1
|
201653-76-1
|
|
XMU-MP-1
|
XMU-MP-1
|
2061980-01-4
|
|
MK-4101
|
5-(3,3-二氟環(huán)丁基)-3-[4-[4-甲基-5-[2-(三氟甲基)苯基]-4H-1,2,4-三唑-3-基]雙環(huán)[2.2.2]辛烷-1-基]-1,2,4-惡二唑
|
935273-79-3
|
|
CCG215022
|
CCG215022
|
1813527-81-9
|
|
KY1220
|
292168-79-7
|
292168-79-7
|
|
Scutellarein
|
野黃芩素
|
529-53-3
|
|
Pz-1
|
1800505-64-9
|
1800505-64-9
|
|
NRX-252262
|
化合物NRX-252262
|
2438637-61-5
|
|
Kemptide
|
肯普肽
|
65189-71-1
|
|
NVP-ACC789
|
N-(3-溴-4-甲基苯基)-4-(4-吡啶甲基)-1-酞嗪胺
|
300842-64-2
|
|
Ciliobrevin A
|
HPI-4
|
302803-72-1
|
|
Ibrutinib deacryloylpiperidine
|
伊布替尼中間體N-2
|
330786-24-8
|
|
Ceritinib dihydrochloride
|
雙鹽酸鹽色瑞替尼
|
1380575-43-8
|
|
Merestinib dihydrochloride
|
N-[3-氟-4-[[1-甲基-6-(1H-吡唑-4-基)-1H-吲唑-5-基]氧基]苯基]-1-(4-氟苯基)-1,2-二氫-6-甲基-2-氧代-3-吡啶甲酰胺二鹽酸鹽
|
1206801-37-7
|
|
Ramucirumab
|
雷莫蘆單抗
|
947687-13-0
|
|
SRI-011381 hydrochloride
|
SRI-011381 (hydrochloride)
|
2070014-88-7
|
|
Insulin (human)
|
重組人胰島素
|
11061-68-0
|
|
Rho-Kinase-IN-1
|
Rho-Kinase-IN-1
|
1035094-83-7
|
|
Ilorasertib hydrochloride
|
ILORASERTIB HYDROCHLORIDE (ABT-348 HYDROCHLORIDE)
|
1847485-91-9
|
|
Toxoflavin
|
毒黃素
|
84-82-2
|
|
IWR-1
|
IWR-1
|
1127442-82-3
|
|
PNU-74654
|
PNU 74654,2-PHENOXYBENZOICACID-[(5-METHYL-2-FURANYL)METHYLENE]HYDRAZIDE
|
113906-27-7
|
|
WAY 316606
|
5-(苯磺?；?-N-(哌啶-4-基)-2-(三氟甲基)苯磺酰胺
|
915759-45-4
|
|
c-Met inhibitor 1
|
3-[(2-甲基-2H-吲唑-5-基)硫基]-6-(1-甲基-1H-吡唑-4-基)-1,2,4-三唑并[4,3-B]噠嗪
|
1357072-61-7
|
|
GZD824
|
GZD824
|
1257628-77-5
|
|
GZD824 dimesylate
|
GZD824DIMESYLATE
|
1421783-64-3
|
|
Indirubin Derivative E804
|
Indirubin Derivative E804
|
854171-35-0
|
|
KYA1797K
|
CS-2581
|
1956356-56-1
|
|
Glabrescione B
|
GLABRESCIONE B
|
65893-94-9
|
|
Dynarrestin
|
Dynarrestin
|
2222768-84-3
|
|
SSTC3
|
SSTC3
|
1242422-09-8
|
|
SB-772077B dihydrochloride
|
SB 772077B DIHYDROCHLORIDE
|
607373-46-6
|
|
VEGFR-2-IN-5
|
N2-[4-[(3-氨基丙基)氨基]苯基]-N4-(5-環(huán)丙基-1H-吡唑-3-基)-2,4-嘧啶二胺
|
1430089-64-7
|
|
BBT594
|
BBT594
|
882405-89-2
|
|
Glesatinib hydrochloride
|
CS-2642
|
1123838-51-6
|
|
EMT inhibitor-1
|
FWMUIOJZHOPPDX-UHFFFAOYSA-N
|
1638526-21-2
|
|
PKI(5-24)
|
THR-THR-TYR-ALA-ASP-PHE-ILE-ALA-SER-GLY-ARG-THR-GLY-ARG-ARG-ASN-ALA-ILE-HIS-ASP
|
99534-03-9
|
|
7-Hydroxy-4-chromone
|
7-羥基色原酮
|
59887-89-7
|